Humane Genomics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $8M

  • Investors
  • 16

Humane Genomics General Information

Description

Developer of a biotechnology platform designed to engineer oncolytic viral therapies for cancer treatment. The company's platform offers RNA-based viral therapies with selective infection, high lytic activity, and systemic delivery, enabling cancer patients to receive targeted, safe, and effective treatment with extended therapeutic duration.

Contact Information

Website
www.humanegenomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 180 Varick Street
  • Floor 6
  • New York, NY 10014
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 180 Varick Street
  • Floor 6
  • New York, NY 10014
  • United States

Humane Genomics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Humane Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 27-Feb-2025 $8M Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
3. Accelerator/Incubator 27-Aug-2021 Completed Generating Revenue
2. Seed Round 14-Jan-2020 Completed Generating Revenue
1. Grant 01-Jan-2017 $500K Completed Generating Revenue
To view Humane Genomics’s complete valuation and funding history, request access »

Humane Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-4
Seed-3
Seed-2
Seed-1 2,066,947 $0.000010 $0.06 $0.06 1x $0.06 5.86%
Seed 8,300,477 $0.000010 $0.48 $0.48 1x $0.48 23.53%
To view Humane Genomics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Humane Genomics Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 12

    Pending

  • Expiring in next 12 mo

Humane Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025254706-A1 Artificial oncolytic viruses and related methods Pending 10-Apr-2024
WO-2025217464-A1 Artificial oncolytic viruses and related methods Pending 10-Apr-2024
AU-2021401049-A1 Modular viral genomes and methods of producing the same Pending 16-Dec-2020
AU-2021401049-A9 Modular viral genomes and methods of producing the same Pending 16-Dec-2020
CA-3205468-A1 Modular viral genomes and methods of producing the same Pending 16-Dec-2020 C12N15/1031
To view Humane Genomics’s complete patent history, request access »

Humane Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Humane Genomics Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Awah Ventures Venture Capital Minority
Humba Ventures Venture Capital Minority
Leo Capital Venture Capital Minority
Mana Ventures Venture Capital Minority
Saraswati Ventures Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Humane Genomics FAQs

  • When was Humane Genomics founded?

    Humane Genomics was founded in 2016.

  • Where is Humane Genomics headquartered?

    Humane Genomics is headquartered in New York, NY.

  • What is the size of Humane Genomics?

    Humane Genomics has 9 total employees.

  • What industry is Humane Genomics in?

    Humane Genomics’s primary industry is Biotechnology.

  • Is Humane Genomics a private or public company?

    Humane Genomics is a Private company.

  • What is the current valuation of Humane Genomics?

    The current valuation of Humane Genomics is .

  • What is Humane Genomics’s current revenue?

    The current revenue for Humane Genomics is .

  • How much funding has Humane Genomics raised over time?

    Humane Genomics has raised $8.12M.

  • Who are Humane Genomics’s investors?

    Awah Ventures, Humba Ventures, Leo Capital, Mana Ventures, and Saraswati Ventures are 5 of 16 investors who have invested in Humane Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process